title: Hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) is a common malignancy worldwide and is a disease of multifactorial etiology. Strong correlations exist between the prevalence of the hepatitis B and C viruses and HCC incidence. HCC treatment may involve surgical resection, liver transplantation, locoregional treatments, and chemotherapy. Prevention of virus-related HCC is contingent upon control of hepatitis types B and C. Universal vaccination against hepatitis B could eliminate hepatitis B-related HCC; however, hepatitis C-related HCC still could occur because a vaccine for hepatitis C currently is not available. Individuals at risk for HCC should be screened for the disease. Early detection could result in improved prognosis and survival.
authors.affiliation: LDesjardins@NYC.RR.com
authors.forename: Lisa A
authors.initials: LA
authors.lastname: Desjardins
mesh_terms: D016604:Aflatoxin B1 / Q000009:adverse effects; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D008403:Mass Screening; D012307:Risk Factors
chemical_list: D016604:Aflatoxin B1